Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures

Hip Fracture Clinical Trial

Official title:

A Randomized Controlled Trial Comparing Single Shot Fascia Iliaca Block With Femoral Nerve Block for Analgesia Following Surgical Fixation of Hip Fractures

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02330302
• Other study ID #: 2014/453/D
• Status: Completed
• Phase: N/A
• First received: December 31, 2014
• Last updated: January 23, 2018
• Start date: August 2014
• Est. completion date: August 2015

Study information

• Verified date: January 2018
• Source: Changi General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hip fractures are common in our elderly population and is associated with pain before and after surgery. The current pain management for patients who have undergone surgery for hip fractures include a combination of oral painkillers, opioids (eg morphine) and regional anaesthesia techniques, which involves the injection of local anaesthetic drugs near nerves supplying the hip joint to numb the operation site. As opioids have many side effects, especially in the elderly patients, regional anaesthesia techniques can help to reduce the use of opioids and the related side effects. This may enhance their recovery and length of hospital stay

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: August 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients scheduled for surgical fixation of hip fracture

• Patients with isolated inter-trochantric fracture

• American Society of Anesthesiologists (ASA) physical status 1 to 3

• Patients who are able to give their own consent

Exclusion Criteria:

• Patients unable to give consent or inability to communicate/ cooperate

• Patients with regular consumption of strong opioids (morphine, oxycodone) or steroids

• Patients with allergy to local anaesthetics or any drugs included in the study

• Patients with contraindications to spinal anaesthesia such as coagulation disorders/ thrombocytopenia and local infection at site of injection

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fracture
• Hip Fractures

Intervention

Drug:
• Ropivacaine
Ultrasound-guided femoral nerve block with Ropivacaine 0.5% 30mls
• Ropivacaine
Ultrasound-guided suprainguinal approach to fascia iliaca block with Ropivacaine 0.5% 30mls

Locations

Country	Name	City	State
Singapore	Changi General Hospital	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Changi General Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	complications associated with intervention	including hematoma, infection, prolonged neurologic deficits, occurence of falls	at 24 hrs post intervention
Primary	Pain scores	resting and dynamic pain scores are obtained pre-intervention, 30mins post intervention (and on positioning for spinal anaesthesia), 1 hr post-operatively and at 24hrs post intervention	up to 24 hours
Secondary	opioid requirement/consumption	need for additional opioids during first 24hrs following intervention record of any opioid related side effects will be kept as well	for first 24 hrs (including intra operatively) following intervention